3699 |
Benefit of Adding Ezetimibe to Statin Therapy in Coronary Patients |
Jong-Young Lee |
Apr. 28. 18 |
3698 |
Non-Invasive Hemodynamic Assessment for ACS Risk |
Bon-Kwon Koo |
Apr. 28. 18 |
3697 |
IVUS-Guided PCI Improves Patient Outcome: The Data Is Clear! |
John McB. Hodgson |
Apr. 28. 18 |
3696 |
Optimal Treatment Strategy for AMI Patients with Non-Culprit Stenosis: The Role of Physiology Guidance |
Joo Myung Lee |
Apr. 28. 18 |
3695 |
Minimalist TAVR with Edwards SAPIEN 3 Valve |
Duk-Woo Park |
Apr. 28. 18 |
3694 |
How to Manage Complication TAVR Case |
Alan C. Yeung |
Apr. 28. 18 |
3693 |
TAVR Experience with Edwards SAPIEN 3 in Korea |
Cheol Woong Yu |
Apr. 28. 18 |
3692 |
Less Invasive Left Ventricular Enhancement(LIVE-Revivent) for Treatment of Advanced Heart Failure: Technique and GLOBAL Data |
Teguh Santoso |
Apr. 28. 18 |
3691 |
Electrical Neuromodulation and Renal Denervation for Heart Failure |
Wojciech Wojakowski |
Apr. 28. 18 |
3690 |
Very Long-term Outcomes After LAA Closure |
Maurice Buchbinder |
Apr. 28. 18 |